Acute Myeloid Leukemia (AML) as a model for cancer therapy

Acute Myeloid Leukemia (AML) as a model for cancer therapy

Bibliographic Details
Main Author:	Farhad eRavandi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2012-10-01
Series:	Frontiers in Oncology
Subjects:	Hematology Leukemia cancer therapy oncology acute myeloid leukemia (AML)
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00139/full

Similar Items

Factors associated with intensity of end-of-life care for patients with acute myeloid leukemia
by: Vaughn, Dagny
Published: (2020)

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)
by: Maryam Nourizadeh, et al.
Published: (2014-11-01)

Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-05-01)

Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo-therapy
by: Thomas Büchner, et al.
Published: (2004-03-01)

Extramedullary Acute Myeloid Leukemia (AML): Leukemic Pleural Effusion, Case Report and Review of the Literature
by: Naveen ePemmaraju, et al.
Published: (2014-06-01)

Therapies for acute myeloid leukemia: vosaroxin
by: Sayar H, et al.
Published: (2017-08-01)

Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
by: Charlotte Calvo, et al.
Published: (2021-02-01)

Preclinical evaluation of NAMPT inhibitor KPT-9274 in Acute Myeloid Leukemia
by: Mitchell, Shaneice Renee
Published: (2019)

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
by: Francesco Tarantini, et al.
Published: (2021-08-01)

The clinical significance of γ-catenin in acute myeloid leukemia
by: Xu J, et al.
Published: (2016-06-01)

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
by: Chen EC, et al.
Published: (2018-06-01)

Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats
by: Brent A. Williams, et al.
Published: (2019-08-01)

Malyglycemia and health outcomes in hospitalized patients with acute myleoid leukemia
by: Storey, Susan
Published: (2016)

Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01)

Clinical and genetic characteristics of acute myeloid leukemia with t(8;21) in children and results of therapy according to protocol AML-MM-2000
by: I. I. Kalinina, et al.
Published: (2014-07-01)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
by: Katherine L. B. Borden, et al.
Published: (2012-11-01)

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
by: Bhuwan Giri, et al.
Published: (2019-05-01)

Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
by: Mareike Rasche, et al.
Published: (2021-05-01)

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
by: Samantha L. Goldman, et al.
Published: (2019-03-01)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01)

Geographic Heterogeneity of the AML1-ETO Fusion Gene in Iranian Patients with Acute Myeloid Leukemia
by: Saeedeh Ghazaey Zidanloo, et al.
Published: (2014-10-01)

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
by: Lin M, et al.
Published: (2018-04-01)

Defining and treating older adults with acute myeloid leukemia who are ineligible for intensive therapies
by: Kristen ePettit, et al.
Published: (2015-12-01)

Translocation ETS leukemia-acute myeloid leukemia 1 (TEL-AML1) gene fusion in childhood acute lymphoblastic leukemia
by: Sri Mulatsih, et al.
Published: (2009-10-01)

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
by: Weisberg E, et al.
Published: (2017-12-01)

Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020-03-01)

Assessing clonal diversity in acute myeloid leukemia
by: Christensen, Weston Daniel
Published: (2016)

Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice
by: Landis R. Walsh, et al.
Published: (2021-01-01)

Global DNA methylation analysis of chronic lymphocytic leukemia and acute myeloid leukemia reveals distinct clinically relevant biological subtypes
by: Giacopelli, Brian John
Published: (2020)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
by: Jing Chen, et al.
Published: (2020-02-01)

CARACTERÍSTICAS CLÍNICO EPIDEMIOLOGICAS DE LOS PACIENTES CON LEUCEMIA AGUDA DEL SERVICIO DE HEMATOLOGIA DEL HOSPITAL ALMANZOR AGUINAGA ASENJO
by: Ana María Polo-Capuñay, et al.
Published: (2014-01-01)

Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group
by: Mareike Rasche, et al.
Published: (2021-02-01)

Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia
by: Xiaoyan Chen, et al.
Published: (2021-08-01)

DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML)
by: Olga Krali, et al.
Published: (2021-06-01)

Descriptive and Analytical Study of Acute Leukemia in Adults in Eastern Algeria
by: Fethi Tebbani, et al.
Published: (2020-12-01)

The incidence of acute myeloid leukemia in Calgary, Alberta, Canada: a retrospective cohort study
by: Andrea Christine Shysh, et al.
Published: (2017-08-01)

Faggot cells in therapy‐related acute myeloid leukemia with inv(16)
by: Ana Vega González de Viñaspre, et al.
Published: (2021-01-01)

Aberrant Phenotype in Iranian Patients with Acute Myeloid Leukemia
by: Mehdi Jahedi, et al.
Published: (2014-03-01)

KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia
by: Shanmin Zhao, et al.
Published: (2014-01-01)

Efficacy and toxicity of cladribine for the treatment of refractory acute myeloid leukemia: a meta-analysis
by: Zhou A, et al.
Published: (2019-05-01)